Acute liver injury associated with the use of ebrotidine, a new H 2 -receptor antagonist

Journal of Hepatology - Tập 31 - Trang 641-646 - 1999
Raúl J Andrade1, M.Isabel Lucena2, Rafael Martin-Vivaldi3, M.Carmen Fernandez4, Flor Nogueras3, Gloria Pelaez5, Antonio Gomez-Outes2, M Dolores Garcia-Escaño1, Vicente Bellot6, Antonio Hervás7, Francisco Cárdenas8, Francisco Bermudez1, Manuel Romero9, Javier Salmerón6
1Liver Unit, Department of Gastroenterology,Spain
2Clinical Pharmacology Service, University Hospital, School of Medicine, Málaga,Spain
3Liver Section, Gastroenterology Service, University Hospital Virgen de las Nieves, Granada,Spain
4Clinical Pharmacology Service, Hospital Torrecardenas, Almeria,Spain
5Gastroenterology Service,Spain
6Gastroenterology Service, University Hospital San Cecilio, Granada,Spain
7Gastroenterology Service, University Hospital Reina Sofia, Cordoba,Spain
8Gastrointestinal Unit, Hospital General Básico, Antequera, Málaga;,Spain
9Gastroenterology Service, University Hospital Virgen de Valme, Sevilla, Spain

Tài liệu tham khảo

Lewis, 1987, Hepatic effects of drugs used in the treatment of peptic ulcer disease, Am J Gastroenterol, 82, 987 Patel, 1996, Ebrotidine, Drugs, 51, 974, 10.2165/00003495-199651060-00006 Romero, 1997, Chronic toxicity of ebrotidine in rats and dogs, Arzneimittelforsch, 47, 498 Romero, 1997, Carcinogenicity studies on ebrotidine, Arzneimittelforsch, 47, 515 Farre, 1997, Tolerability and pharmacokinetics of ebrotidine in healthy subjects given single and repeated oral doses, Arzneimittelforsch, 47, 528 Anonymous, 1996, Ebrotidine may combine antisecretory and gastroprotective properties, Drugs Ther Perspect, 8, 4 Andrade, 1997, Drug-induced hepatotoxicity: preliminary reults from a surveillance program in South Spain, J Hepatol, 26, 297 1990, Report of an International Consensus Meeting. Criteria of druginduced liver disorders, J Hepatol, 11, 272 Anonimo, 1998, Retirada de la Ebrotidina por su posible asociación a casos de hepatitis grave, Alerta de Farmacovigilancia, 18, 1 Garcia Rodriguez, 1994, Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors, Arch Intern Med, 154, 311, 10.1001/archinte.154.3.311 Bort, 1999, Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity, J Pharmacol Exp Ther, 288, 65 Reddy, 1989, Schiff ER Amoxicillin-clavulanate potassium-associated cholestasis, Gastroenterology, 96, 1135, 10.1016/0016-5085(89)91633-8 Zimmerman, 1997, Acetaminophen poisoning and NSAID toxicity. Liver injury update: clinical implications and mechanism role of cells of the liver, AASLD Postgraduate Course, 49 Biour, 1996, Hépatotoxicité des médicaments, Gastroenterol Clin Biol, 20, 744 Zimmerman, 1993, Hepatotoxicity, Dis Month, 39, 675 Farrel, 1994 García Rodríguez, 1997, The risk of acute liver injury associated with cimetidine and other acidsuppressing anti-ulcer drugs, Br J Clin Pharmacol, 43, 183, 10.1046/j.1365-2125.1997.05268.x Rush, 1985, Mechanism of oxmetidine (SKαF 92994) cytotoxicity in isolated rat hepatocytes, J Pharmacol Exp Ther, 233, 741 Black, 1987, Hepatotoxic and hepatoprotective potential of histamine (H2)-receptor antagonists, Am J Med, 83, 68, 10.1016/0002-9343(87)90814-X García Rodríguez, 1997, A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom, Pharmacotherapy, 17, 721 Black, 1984, Possible ranitidine hepatotoxicity, Ann Intern Med, 101, 203, 10.7326/0003-4819-101-2-208 Gasbarrini, 1997, Acute liver injury related to the use of niperotidine, J Hepatol, 27, 583, 10.1016/S0168-8278(97)80365-0 Bakke, 1995, Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective, Clin Pharmacol Ther, 58, 108, 10.1016/0009-9236(95)90078-0